187 related articles for article (PubMed ID: 8790214)
1. Somatostatin-receptor scintigraphy of subcutaneous and thyroid metastases from bronchial carcinoid.
Krausz Y; Pfeffer MR; Glaser B; Lafair J
J Nucl Med; 1996 Sep; 37(9):1537-9. PubMed ID: 8790214
[TBL] [Abstract][Full Text] [Related]
2. Somatostatin-receptor scintigraphy in the management of gastroenteropancreatic tumors.
Krausz Y; Bar-Ziv J; de Jong RB; Ish-Shalom S; Chisin R; Shibley N; Glaser B
Am J Gastroenterol; 1998 Jan; 93(1):66-70. PubMed ID: 9448177
[TBL] [Abstract][Full Text] [Related]
3. Primary renal carcinoid tumor with liver metastases detected with somatostatin receptor imaging.
Mufarrij P; Varkarakis IM; Studeman KD; Jarrett TW
Urology; 2005 May; 65(5):1002. PubMed ID: 15882749
[TBL] [Abstract][Full Text] [Related]
4. [111In-pentetreotide in the study of tumors expressing somatostatin receptors].
Mateos Fernández J; Pons Pons F; Fuster Pelfort D; Vidal-Sicart S; Lomeña Caballero F; Herranz García-Romero R
Rev Esp Med Nucl; 1999 Oct; 18(5):325-30. PubMed ID: 10562660
[TBL] [Abstract][Full Text] [Related]
5. [Imaging of metastases from thyroid carcinomas using 111In-pentetreotide scintigraphy].
Görges R; Eissner D; Kahaly G; Voges E; Kersjes W; Bockisch A
Nuklearmedizin; 1995 Aug; 34(4):165-9. PubMed ID: 7675648
[TBL] [Abstract][Full Text] [Related]
6. 111In-octreotide scintigraphy in endocrine tumors. Preliminary data.
Cremonini N; Furno A; Sforza A; Chiarini V; Graziano E; Zampa G; Turba E
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):116-20. PubMed ID: 9002767
[TBL] [Abstract][Full Text] [Related]
7. Improved visualization of carcinoid liver metastases by indium-111 pentetreotide scintigraphy following treatment with cold somatostatin analogue.
Dörr U; Räth U; Sautter-Bihl ML; Guzman G; Bach D; Adrian HJ; Bihl H
Eur J Nucl Med; 1993 May; 20(5):431-3. PubMed ID: 8100192
[TBL] [Abstract][Full Text] [Related]
8. Radiolabeled somatostatin analog scintigraphy in differentiated thyroid carcinoma.
Tenenbaum F; Lumbroso J; Schlumberger M; Caillou B; Fragu P; Parmentier C
J Nucl Med; 1995 May; 36(5):807-10. PubMed ID: 7738653
[TBL] [Abstract][Full Text] [Related]
9. Comment on primary localization of an ectopic ACTH-producing bronchial carcinoid tumor by indium111 pentetreotide scintigraphy.
Reincke M; Allolio B; Arlt W; Körber C
J Clin Endocrinol Metab; 1999 Sep; 84(9):3399-400; author reply 3402-3. PubMed ID: 10487718
[No Abstract] [Full Text] [Related]
10. SPECT improves accuracy of somatostatin receptor scintigraphy in abdominal carcinoid tumors.
Schillaci O; Scopinaro F; Angeletti S; Tavolaro R; Danieli R; Annibale B; Gualdi G; Delle Fave G
J Nucl Med; 1996 Sep; 37(9):1452-6. PubMed ID: 8790191
[TBL] [Abstract][Full Text] [Related]
11. The incidental discovery of follicular thyroid cancer with in-111 pentetreotide scintigraphy in a patient with carcinoid tumor of the lung.
Villa G; Ratto GB; Carletto M; Rouhanifar H; Piccardo A; Tommasi L; Altrinetti V; Mereu C; Mariani G
Clin Nucl Med; 2003 Jan; 28(1):45-6. PubMed ID: 12493962
[No Abstract] [Full Text] [Related]
12. Localization of adrenocorticotropic hormone-secreting bronchial carcinoid tumor by somatostatin-receptor scintigraphy.
Weiss M; Yellin A; Husza'r M; Eisenstein Z; Bar-Ziv J; Krausz Y
Ann Intern Med; 1994 Aug; 121(3):198-9. PubMed ID: 7912484
[No Abstract] [Full Text] [Related]
13. Neuroendocrine tumors and somatostatin: imaging techniques.
de Herder WW; Kwekkeboom DJ; Valkema R; Feelders RA; van Aken MO; Lamberts SW; van der Lely AJ; Krenning EP
J Endocrinol Invest; 2005; 28(11 Suppl International):132-6. PubMed ID: 16625862
[TBL] [Abstract][Full Text] [Related]
14. Metastatic carcinoid tumor imaged with CT and a radiolabeled somatostatin analog: a case report.
Lobrano MB; McCarthy K; Adams L; Neitzschman H
Am J Gastroenterol; 1997 Mar; 92(3):513-5. PubMed ID: 9068482
[TBL] [Abstract][Full Text] [Related]
15. [Bronchial carcinoid tumor and scintigraphy of somatostatin receptors: detection of bone metastasis].
Banzo J; Abós MD; Prats E; García F; Freile E; Razola P; Escalera T
Rev Esp Med Nucl; 2001 Oct; 20(6):431-8. PubMed ID: 11578577
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness analysis of somatostatin receptor scintigraphy.
Kwekkeboom DJ; Lamberts SW; Habbema JD; Krenning EP
J Nucl Med; 1996 Jun; 37(6):886-92. PubMed ID: 8683305
[TBL] [Abstract][Full Text] [Related]
17. High-dose indium 111In pentetreotide radiotherapy for metastatic atypical carcinoid tumor.
Meyers MO; Anthony LB; McCarthy KE; Drouant G; Maloney TJ; Espanan GD; Woltering EA
South Med J; 2000 Aug; 93(8):809-11. PubMed ID: 10963516
[TBL] [Abstract][Full Text] [Related]
18. A reappraisal of the utility of somatostatin receptor scintigraphy in patients with ectopic adrenocorticotropin Cushing's syndrome.
Tsagarakis S; Christoforaki M; Giannopoulou H; Rondogianni F; Housianakou I; Malagari C; Rontogianni D; Bellenis I; Thalassinos N
J Clin Endocrinol Metab; 2003 Oct; 88(10):4754-8. PubMed ID: 14557451
[TBL] [Abstract][Full Text] [Related]
19. Factor analysis of dynamic series (FADS) in somatostatin receptor imaging.
Kolesnikov-Gauthier H; Huglo D; Nocaudie M; Marchandise X
J Nucl Med; 1999 Jan; 40(1):33-9. PubMed ID: 9935053
[TBL] [Abstract][Full Text] [Related]
20. [Somatostatin receptor scintigraphy in medullary thyroid carcinomas, GEP and carcinoid tumors].
Eising EG; Farahati J; Bier D; Knust EJ; Reiners C
Nuklearmedizin; 1995 Feb; 34(1):1-7. PubMed ID: 7724358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]